| Reduced Risk Status: |
|
| IPM Compatibility: |
Per Requester: Very Good Fit; Needed due to good IPM fit and not expected to have activity on our beneficials. Need a late Blight material.
|
| Reasons for need: |
Late Blight. Needed due to good IPM fit and not expected to have activity on our beneficials. Need a late Blight material.:07/24;
|
| Requesting State(s): |
CA:Bagley, Z ; FL:Bledsoe, M* ;
|
| PCR Use Pattern: |
Use Xivana Prime product; 50ml/100 ml water + adjuvant; 2 to 3 foliar applications; 7-14 day re-treatment interval; 1-3 day PHI
|
| EPA Default Residue Trials: |
ANY 4 TRIALS
|
| IR-4 Residue Trial Plan: |
|
| Residue Protocol Use Pattern: |
|
| Efficacy/Crop Safety (E/CS) Data Required: |
|
| E/CS Research Comments: |
|
| Label Use Pattern Submitted To EPA: |
|
| EPA PIF Status: |
|
| EPA Status: |
|
| EPA PRIA Date: |
|
| MRID: |
|
| Comments: |
Key Export Market: Canada; Researchers will need to have late blight pathogen inoculum to conduct trials:07/24/sb; Bayer is not prepared to support this project in 2024, and requests the project be placed on (Mfg) HOLD for possible future consideration:09/24/sb;
|
| International Status: |
|
| Archive Location: |
|
| QA Archive: |
|